Buprenorphine Addiction Treatment

Medycznie nadzorowane leczenie uzależnienia od buprenorfiny z pełnym zabezpieczeniem pacjenta
Wnętrze ośrodka leczenia uzależnień prezentujące uporządkowany proces opieki klinicznej

Buprenorphine Addiction Treatment

Confidential inpatient treatment for buprenorphine use disorder, provided under continuous medical and psychiatric supervision. The clinical approach encompasses assessment, safe stabilisation and therapy targeting the mechanisms of dependency and relapse risk. All clinical contact is strictly confidential and non-binding.

As part of our clinical approach to treatment of addiction to opioid painkillers, we offer an individualised inpatient programme for patients with buprenorphine use disorder. Every case is assessed individually.

Buprenorphine - brand names by country

United StatesSuboxone, Sublocade, Brixadi, Belbuca, Butrans, Bunavail, Zubsolv, Buprenex
United KingdomBuTrans, Buvidal, Espranor, Suboxone, Subutex (and buprenorphine patches)
CanadaButrans, Suboxone, Sublocade, Probuphine, Mylan-Buprenorphine/Naloxone, Teva-Buprenorphine/Naloxone

What is buprenorphine

Buprenorphine is an opioid medication used in medicine for the treatment of pain and for the treatment of opioid use disorder (for example in substitution programmes), always in defined clinical indications and under medical supervision. Despite its therapeutic application, some individuals may develop misuse, dependency or compulsive use patterns.

When urgent medical attention is required

Urgent medical attention is required if any of the following occur during withdrawal: seizures, loss of consciousness, severe disorientation, symptoms of psychosis, aggressive behaviour disproportionate to the situation, severe chest pain, shortness of breath or suspected overdose. In these situations, no attempt should be made to manage the condition independently. Patient safety and rapid clinical assessment are always the priority. In any life-threatening or health-threatening situation, emergency services should be contacted immediately by calling 112 or 999.

Buprenorphine and dependency - an important clinical distinction

Not every patient taking buprenorphine is "addicted" in the behavioural sense. Clinical practice distinguishes between physical dependence (physiological adaptation, withdrawal symptoms on abrupt discontinuation), opioid use disorder (loss of control, compulsive use despite harm), and therapeutic use within medically supervised treatment. Assessment focuses on the patient's functioning, loss of control, consequences and risk - not solely on the fact of taking the medication.

How a problem with buprenorphine use can develop

In some individuals, risk increases when patterns such as the following emerge: taking the medication outside the treatment plan or in doses other than prescribed; using it to reduce tension, anxiety, withdrawal symptoms or to "stabilise" mood; obtaining the medication from multiple sources or outside the medical system; combining it with other psychoactive substances; entrenched fear of functioning without the medication and increasing loss of control.

Symptoms of a problem with buprenorphine

Psychological and behavioural symptoms

  • compulsive thinking about the dose and securing access to the medication
  • increasing anxiety, irritability or low mood when attempting to reduce use
  • loss of control over the dosing pattern
  • denial of the extent of the problem despite consequences
  • social withdrawal, decline in professional or family functioning

Physical and functional symptoms

  • sleep and energy disturbances
  • appetite fluctuations and gastrointestinal complaints
  • withdrawal symptoms on abrupt changes to the dosing pattern
  • increased risk of complications when combined with CNS depressants (e.g. alcohol, sedatives)

Health risks and situations requiring urgent assessment

A problem with buprenorphine use can carry significant medical risk, especially when the following co-occur: polysubstance use, depression, anxiety disorders or previous episodes of overdose. Particular caution is required when opioids are combined with other CNS-depressant substances, as this substantially increases the risk of complications.

Buprenorphine addiction treatment at Zeus Detox & Rehab

Treatment of opioid use disorder is provided exclusively in an inpatient setting, under continuous medical and psychiatric supervision. The process begins with detailed clinical assessment encompassing the history of medication use, the patient's health status and risk factors for relapse or complications.

Care is delivered in a discreet clinical environment, with full respect for the patient's privacy and dignity. The treatment plan is individualised and adjusted in accordance with the course of therapy and clinical response.

Stages of buprenorphine addiction treatment

Buprenorphine addiction treatment at Zeus Detox & Rehab typically proceeds through four main clinical stages:

Stage 1: Clinical assessment and stabilisation

Establishing the diagnosis, risk assessment, medical and psychiatric safeguarding, and preparation of the treatment plan. Detailed medical and psychiatric history, analysis of the buprenorphine use pattern and other substances, assessment of withdrawal and somatic complication risk, laboratory tests where indicated, and diagnosis of co-occurring psychiatric disorders.

Stage 2: Addiction therapy and co-occurring difficulties

Monitoring of physical and psychological state, management of withdrawal symptoms and discomfort under supervision, pain and functioning assessment without escalation of opioid pharmacology, treatment of co-occurring health problems where present. Therapeutic work on loss of control, the function of use, emotional regulation and relapse patterns.

Stage 3: Psychiatric treatment and psychotherapy

Individual psychotherapy targeting the mechanisms of compulsive use, work on emotional regulation, stress and relapse triggers, treatment of anxiety and depressive disorders where co-occurring, and building a relapse prevention and post-discharge safety plan.

Stage 4: Aftercare planning

Individual post-discharge treatment plan, coordination of outpatient therapy or continued inpatient treatment, psychiatric support and long-term stabilisation strategy.

Treatment of opioid use disorder, including buprenorphine, requires individual medical qualification and may involve significant medical risk. In cases of severe complications or risk to life, the patient may be transferred to hospital treatment at a higher level of care. The information on this page is educational in nature and does not replace medical consultation.

When inpatient buprenorphine treatment is indicated

For whom inpatient treatment may be appropriate

  • loss of control over buprenorphine use or compulsive use
  • recurrent relapse or ineffectiveness of outpatient treatment
  • co-occurring anxiety, depressive disorders or other addictions
  • significant deterioration in social or professional functioning
  • need for structured stabilisation in an environment free from triggers

When another level of care is required

  • acute life-threatening condition or severe somatic instability requiring hospitalisation
  • acute psychosis or high safety risk requiring an acute ward
  • absence of patient consent to inpatient treatment

Every case requires individual clinical qualification.

FAQ

Does taking buprenorphine always mean addiction?
No. The medication is sometimes used therapeutically, and clinical assessment focuses on loss of control, consequences and patient functioning.
Should buprenorphine be discontinued under medical supervision?
Yes. Abrupt changes to the dosing pattern can trigger intensified symptoms and increase the risk of relapse.
Does treatment include psychotherapy?
Yes. Psychotherapy is central to treating the mechanisms of compulsive use and to relapse prevention.
Is treatment confidential?
Yes. The entire treatment process is covered by medical confidentiality.
How long does inpatient treatment last?
Treatment duration is determined individually following clinical assessment and depends on medical stability and therapeutic needs.
Schody w ośrodku leczenia z dużymi oknami i widokiem na zieleń
Ośrodek leczenia stacjonarnego z lotu ptaka w otoczeniu zieleni
logo zeus detox & rehab

Confidential Clinical Contact

CLINICAL INQUIRY

The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.

Related Treatment Areas

Clinical Contact

Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.

Scope of Treatment and Informational Nature of Content

Inpatient treatment provided at Zeus Detox & Rehab is clinical in nature and focuses on medical stabilization, psychiatric assessment, and therapeutic intervention appropriate to the diagnosed condition and stage of the disorder. The scope and structure of treatment are determined individually by the clinical team based on the patient’s current health status and applicable medical standards.

The information presented on this website is for educational and informational purposes only. It does not constitute medical advice and should not be used as a basis for self-directed treatment decisions. Addiction and mental health treatment require individual medical qualification and clinical assessment.

Content Author

Content published on this website is prepared by the interdisciplinary clinical team of Zeus Detox & Rehab in collaboration with physicians, psychiatrists, psychotherapists, clinical psychologists, and medical staff. Materials are developed on the basis of current medical knowledge and clinical experience in inpatient addiction treatment.